Suvretta Capital Management’s Inozyme Pharma INZY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-1,013,216
| Closed | -$4.14M | – | 94 |
|
|
2022
Q1 | $4.14M | Hold |
1,013,216
| – | – | 0.13% | 65 |
|
|
2021
Q4 | $6.91M | Buy |
1,013,216
+26,816
| +3% | +$183K | 0.13% | 67 |
|
|
2021
Q3 | $11.4M | Buy |
986,400
+621,228
| +170% | +$7.2M | 0.19% | 63 |
|
|
2021
Q2 | $6.22M | Buy |
365,172
+23,745
| +7% | +$405K | 0.09% | 86 |
|
|
2021
Q1 | $6.76M | Buy |
341,427
+127,116
| +59% | +$2.52M | 0.1% | 81 |
|
|
2020
Q4 | $4.42M | Buy |
+214,311
| New | +$4.42M | 0.06% | 81 |
|